Ren Mo

Ren Mo


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2015 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JPJingtao Peng
Jingtao Peng
RMRen Mo
Ren Mo
JMJian Ma
Jian Ma
JFJie Fan
Jie Fan
Renal cell carcinoma (RCC) is characterized by inherent resistance to chemotherapy. Earlier studies demonstrated that microRNAs (miRNAs) might be involved in the chemosensitivity of cancers. MicroRNA let-7, a putative tumor suppressor, is dysregulated in many cancers. Our study aims to investigate the exact role of let-7 in chemotherapy sensitivity of 5-fluorouracil (5-FU) in RCC. The clinical significance of let-7b and let-7c expression in surgically resected specimens was assessed by qRT-PCR. Cell proliferation assay and colony formation assay were used to assess the survival of 786-O cells treated with let-7b or let-7c combined with 5-FU. Western blot was used to detect the expression of Akt2 and caspase-7. Luciferase assay was used to detect the direct binding of let-7b and let-7c to the 3′-untranslated region (UTR) of Akt2. Expression of let-7b and let-7c was significantly decreased in 32 paired clear cell renal cell carcinoma tissue specimens and the dysregulation of let-7b was associated with pathological grade. Transfection of let-7b or let-7c combined with 5-FU inhibited proliferation and potentiated the antitumor efficacies of 5-FU at tolerated concentration. let-7b and let-7c suppressed the luciferase activity of reporter plasmid containing the 3′-UTR of Akt2. Overexpression of let-7b and let-7c reduced Akt2 expression, and Akt2 inhibition enhanced the sensitivity to 5-FU by affecting apoptotic pathway. Expression of let-7b and let-7c was frequently decreased in clear cell renal cell carcinoma tissues. The dysregulation of let-7b and let-7c may be involved in chemoresistance of RCC cells to 5-FU by down-regulating Akt2.

22 July 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
RMRen Mo
Ren Mo
JDJianati Dawulieti
Jianati Dawulieti
NCNing Chi
Ning Chi
ZWZiping Wu
Ziping Wu
ZYZhizhong Yun
Zhizhong Yun
KMKewei Ma
Kewei Ma
Systemic administration of platinum-based drugs has obvious limitations in the treatment of advanced bladder cancer (BC) owing to lower tumor accumulation and uncontrolled release of chemotherapeutics. There is an urgent need for advanced strategies to overcome the current limitations of platinum-based chemotherapy, to achieve maximal therapeutic outcomes with reduced side effects. In this study, self-polymerized platinum (II)-polydopamine nanocomplexes (PtPDs) were tailored for efficient chemo-photoimmunotherapy of BC. PtPDs with high Pt loading content (11.3%) were degradable under the combination of a reductive tumor microenvironment and near-infrared (NIR) light irradiation, thus controlling the release of Pt ions to achieve efficient chemotherapy. In addition, polydopamine promoted stronger photothermal effects to supplement platinum-based chemotherapy. Consequently, PtPDs provided effective chemo-photothermal therapy of MB49 BC in vitro and in vivo, strengthening the immunogenic cell death (ICD) effect and robust anti-tumoral immunity response. When combined with a PD-1 checkpoint blockade, PtPD-based photochemotherapy evoked systemic immune responses that completely suppressed primary and distant tumor growth without inducing systemic toxicities. Our work provides a highly versatile approach through metal-dopamine self-polymerization for the precise delivery of metal-based chemotherapeutic drugs, and may serve as a promising nanomedicine for efficient and safe platinum-based chemotherapy for BC.

5 September 2023 in Redox Biology
Verified
Journal Article
Open access
YCYingji Chen
Yingji Chen
DJDongyue Jiao
Dongyue Jiao
HHHuiying He
Huiying He
HSHuiru Sun
Huiru Sun
YLYajuan Liu
Yajuan Liu
CWChenji Wang
Chenji Wang
The mechanistic target of the rapamycin (mTOR) pathway, which participates in the regulation of cellular growth and metabolism, is aberrantly regulated in various cancer types. The mTOR complex 2 (mTORC2), which consists of the core components mTOR, Rictor, mSin1, and mLST8, primarily responds to growth signals. However, the coordination between mTORC2 assembly and activity remains poorly understood. Keap1, a major sensor of oxidative stress in cells, functions as a substrate adaptor for Cullin 3-RING E3 ubiquitin ligase (CRL3) to promote proteasomal degradation of NF-E2-related factor 2 (NRF2), which is a transcription factor that protects cells against oxidative and electrophilic stress. In the present study, we demonstrate that Keap1 binds to mLST8 via a conserved ETGE motif. The CRL3Keap1 ubiquitin ligase complex promotes non-degradative ubiquitination of mLST8, thus reducing mTORC2 complex integrity and mTORC2-AKT activation. However, this effect can be prevented by oxidative/electrophilic stresses and growth factor signaling-induced reactive oxygen species (ROS) burst. Cancer-derived Keap1 or mLST8 mutations disrupt the Keap1-mLST8 interaction and allow mLST8 to evade Keap1-mediated ubiquitination, thereby enhancing mTORC2-AKT activation and promoting cell malignancy and remodeling cell metabolism. Our findings provide new insights into the molecular mechanisms of Keap1/mLST8 mutation-driven tumorigenesis by promoting mTORC2-AKT activation, which is independent of the canonical NRF2 pathway.

19 September 2024 in Genomics
Verified
Journal Article
Open access
LSLiying Shan
Liying Shan
HFHaitao Fan
Haitao Fan
JGJing Guo
Jing Guo
HZHeyang Zhou
Heyang Zhou
FLFengguo Li
Fengguo Li
YZYang Zhou
Yang Zhou
Obesity poses risks to oocyte maturation and embryonic development in mice and humans, linked to gut microbiota dysbiosis and altered host metabolomes. However, it is unclear whether symbiotic gut microbes have a pivotal role in oocyte quality. In mouse models of fecal microbiota transplantation, we demonstrated aberrant meiotic apparatus and impaired maternal mRNA in oocytes, which is coincident with the poor developmental competence of embryos. Using metabolomics profiling, we discovered that the cytosine and cytidine metabolism was disturbed, which could account for the fertility defects observed in the high-fat diet (HFD) recipient mice. Additionally, cytosine and cytidine are closely related with gut microbiota dysbiosis, which is accompanied by a notable reduction of abundance of Christensenellaceae R-7 group in the HFD mice. In summary, our findings provided evidence that modifying the gut microbiota may be of value in the treatment of infertile female individuals with obesity.

26 November 2025 in Journal of Advanced Research
Verified
Journal Article
Open access
YLYan Liu
Yan Liu
KXKai Xiao
Kai Xiao
ZWZiping Wu
Ziping Wu
QWQiang Wu
Qiang Wu
XXXiaochun Xie
Xiaochun Xie
DSDan Shao
Dan Shao
Bacterial cystitis is a prevalent infectious condition that is primarily caused by uropathogenic Escherichia coli (E. coli). The rapid and precise identification of this pathogen is crucial for guiding timely and effective clinical intervention. Urinary cell-free DNA (cfDNA) has emerged as a promising biomarker for cystitis, yet its complex origins from both inflammatory and infectious processes pose challenges in distinguishing bacterial from non-bacterial etiologies. Here, we developed an innovative image-based, machine learning-assisted fluorescent detection system for simultaneous quantitative and qualitative analysis of urinary cfDNA to diagnose bacterial cystitis. The detection system utilizes polyethyleneimine (PEI)-functionalized glass slides for efficient cfDNA enrichment, followed by fluorescence imaging with propidium iodide labeling. The performance of the detection system was rigorously validated using a bacterial cystitis mouse model and human urine specimens. This platform enables rapid quantification of cfDNA within 20 min, with a calibration range of 31.25-4000 ng mL-1 and a detection limit of 20.29 ng mL-1. Integration with the YOLOv5 object detection algorithm facilitates automated analysis of cfDNA fluorescence spot patterns, revealing distinct size distributions that differentiate bacterial (77.12 % smaller spots) from non-bacterial cystitis (13.87 % smaller spots). Applied to 148 clinical urine samples, this approach achieved a diagnostic accuracy of 94.43 %, with 94.45 % sensitivity and 94.35 % specificity for bacterial cystitis, markedly improving upon conventional methods (65.96 % specificity, 78.22 % sensitivity). Requiring no urine pretreatment, this rapid, on-site platform represents a transformative advance in point-of-care testing (POCT) for bacterial cystitis, with potential applications for digital biomarker detection in diverse inflammatory and infectious diseases.

1 April 2025 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
PDF file
ZSZikun Shen
Zikun Shen
YHYan He
Yan He
RMRen Mo
Ren Mo
DSDan Shao
Dan Shao
Introduction: Whole-cell tumor vaccines are advantageous because of their ability to induce a broad and multifaceted immune response through the presentation of a wide range of tumor antigens, thereby enhancing the ability of the immune system to recognize and target cancerous cells.Method: In this study, we present a multifunctional vaccine that consists of manganese-mineralized tumor cells and positively charged polymer-immobilized CpG. The Mn2+ and CpG released from the engineered vaccine facilitate the maturation of dendritic cells through the activation of the cGAS-STING and TLR9 pathways, respectively.Result: As a consequence, the engineered vaccine derived from B16F10 cells exhibited a pronounced tumor-suppressive effect, reducing the tumor volume to approximately one-fifth of that in the control group, and significantly extending survival to day 30 in B16F10 tumor-bearing mice. This superior therapeutic outcome is associated with enhanced activation of dendritic cells, increased infiltration of NK and CD8+ T cells, and increased production of immune cytokines within the tumor microenvironment.Discussion: Together, our study highlights the immense potential of engineering bioactive mineralized tumor cells to facilitate whole-cell tumor vaccine-based immunotherapy.